September 28, 2011

Weight Loss Drug Changes Label to Reflect Liver Injury Risk

The Food and Drug Administration recently revealed more than a dozen cases of severe injuries to patient’s livers who used the drug orlistat for a duration of nearly ten years, said a New York Injury Lawyer.
Orlistat, also known as Alli and Xenical, will be changing its label to reflect these new risks, which were uncovered by the FDA’s review, according to New York Injury Lawyers.
The new label will include safety information warning patients that Orlistat will increase their risk for severe liver injury when taken over a period of ten years.
Lawyers clarified that the drug Orlistat does not “cause” liver injury so patients should be told to contact physicians and other health care professionals only if they experience symptoms that may include but are not limited to itchy, yellow eyes or skin, dark urine, light colored stool and/or a loss of appetite. Doctors in Staten Island and Westchester County look for these signs before they treat the illness.
Authorities estimate that nearly 40 million people worldwide have used Alli or Xenical and so far one case of liver injury has been reported in the United States involving Alli and twelve cases of liver injury have been reported in foreign countries involving Xenical.
It is strongly recommended to discontinue use of the drug Orlistat if any of these symptoms should or arise of if liver injury is suspected. Physicians and Healthcare professionals should report any of these findings to the FDA right away.
An Orlistat representative was not available for comment, according to New York City Injury Lawyers.

Continue reading "Weight Loss Drug Changes Label to Reflect Liver Injury Risk" »

September 13, 2011

Lawsuits continue to grow against Yasmin birth control and its unexpected side effects

NY Product Liability Lawyers say the lawsuits against Bayer Corporation continue to grow in regards to the it’s birth control products Yaz and Yasmin.

In its most recent case, a woman has charged that Yaz birth control pills led to a severe gall bladder problem resulting in surgery.

“I was never warned properly by either Yaz birth control or Bayer Corp. about this type of a side effect,” the woman claimed. She goes on to charge that Yasmin Birth Control and Bayer were aware of the risks and neglected to warn women of the possible serious health risks.

“This woman had to have her gall bladder removed and continues to suffer with severe stomach cramps and frequent diarrhea,” said a NY Product Liability Lawyer and added, “She never would have used this product had she been properly warned.”

As mentioned in the lawsuit, the woman only took the birth control pills to regulate her menstrual cycle. She claims she followed the exact directions for taking the product. Not long after that she experienced the severe stomach cramps and had to have her gall bladder removed..

Currently, there are more than 6,000 pending charges against the companies that manufacture Yaz, Yasmin and their generic counterparts, Gianvi and Ocella explained a NY Product Liability Lawyer. The complaints consistently allege that the manufacturers of the drug did not adequately research possible side effects of their birth control products and did not warn customers of the risk of gallbladder problems, pulmonary embolism, deep vein thrombosis (DVT) and blood clots.

Lawyers pointed out that three bellwether trials have been ordered in the federal consolidated multidistrict litigation in regards to Yasmin and Yaz and have been set for later in 2011 and early 2012. They say the results of those bellwether trials will help determine how settlements are reached in the pending Yasmin and Yaz lawsuits.

Other lawsuits are currently under investigation in Canada as are cases in Manhattan and Staten Island.

Bayer’s response to these allegations states that there is no evidence that Yaz has higher risks than other birth control methods..

Continue reading "Lawsuits continue to grow against Yasmin birth control and its unexpected side effects " »